
|Videos|June 9, 2017
Immune Correlates of Pathologic Response in Bladder Cancer Patients Undergoing Chemotherapy
Author(s)Phillip Abbosh, MD, PhD
Phillip Abbosh, MD, PhD, assistant professor, Fox Chase Cancer Center, discusses immune correlates of pathologic response in bladder cancer patients undergoing neoadjuvant chemotherapy.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Teclistamab Plus Daratumumab Significantly Improves Survival in R/R Myeloma
2
Poll Results Reveal Readers’ Top Abstracts at SABCS 2025
3
Pirtobrutinib Superior to BR in First-Line CLL/SLL: BRUIN CLL-313 Results
4
Pelabresib Plus Ruxolitinib Benefits Spleen, Symptoms in Myelofibrosis
5









































